QIAGEN’s Biomedical Tissue Management System
addresses the major issue facing biomedical researchers in sample processing
and analysis: the
low degree of standardization and insufficient quality-controlled
protocols.
The system comprises a chain of integrated products to standardize all
steps of the workflow that starts with archived or prospectively collected
tissues and ends with data analysis. This ensures comparability and reproducibility of data in clinical case-controlled and population-based studies, facilitating biomarker discovery and, ultimately, the development of diagnostics and therapeutics.
